Phosphatidylethanol (PEth) in the blood is a biomarker for alcohol consumption and is in the body an unnatural phospholipid that can only be formed in presence of alcohol, which theoretically provides 100% diagnostic specificity for alcohol.
Tamoxifen is widely prescribed for women with breast cancer and a 5- to 10-year treatment is recommended to prevent recurrence of the cancer. Tamoxifen is a prodrug, it must be metabolized in the body to be active; the primary active metabolites are z-endoxifen and 4-hydroxy tamoxifen. redhot diagnostics has developed a system for Therapeutic Dose Monitoring to help these women to get a correct dose of tamoxifen.
Elevated levels of Methylmalonic acid (MMA) are an indication of vitamin B12 deficiency. redhot has developed a new method for determination of methylmalonic acid that circumvents the problem with background from MMA in blank blood, using the HILIC separation technique. It is a very robust and sensitive method. The LC-MS/MS application is intended for the quantitative determination of Methylmalonic acid (MMA) in serum/plasma (whole blood), and is available as a prototype.
redhot diagnostics has developed a new blood sampling kit, rhelise ™ kit. The kit is intended to be used by a layperson to collect capillary whole blood for analysis of biomarkers and drug metabolites. The capillary takes typically 20 - 70 µL of blood. The kit is developed for PEth, Tamoxifen and Methylmalonic Acid (B-vitamin deficiency)
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story.
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story and let your users see.
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story and let your users see.
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story and let your users see.
redhot diagnostics AB is a company that offers state-of-the art diagnostic products to research and routine laboratories at hospitals. Using our patent-pending rhelise™ kit, we are enabling diagnostic testing and therapeutic drug monitoring of patients in their home environment.
Redhot signs distribution agreement with PM Separation for Australia. PM Separation will be our exclusive distributor for the commercialization of our products
ESMO Breast cancer congress 2023 The collaboration project between Assoc. Prof. Elham Hedaity at Karolinska Instutet/ Hospital and redhot diagnostics was presented
Find out more about the latest advancements on our tamoxifen therapeutic drug monitoring home testing. A clinical study in patients on adjunct